Press Releases
January 18, 2011
Gilead Sciences to Release Fourth Quarter and Year End 2010 Financial Results on Tuesday, January 25, 2011
FOSTER CITY, Calif., Jan 18, 2011 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its fourth quarter and year end 2010 financial results will be released on Tuesday, January 25, 2011, at 4:05 p.m. Eastern Time. At 5:00 p.m. Eastern Time, Gilead's management will host a conference call to discuss the company's financial results for the fourth quarter and full year 2010 and provide a general business update and financial guidance for 2011. The conference call will be accessible via the internet from the company's website.
To access the webcast link, log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 1-866-788-0542 (U.S.) or 1-857-350-1680 (international) and dial the participant passcode 29518282 to access the call. Telephone replay is available approximately two hours after the call through 6:30 p.m. Eastern Time, January 28, 2011. To access the replay, please call 1-888-286-8010 (U.S.) or 1-617-801-6888 (international) and dial the participant passcode 66339232. The webcast will be archived on www.gilead.com for one year.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
SOURCE: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715
Investor Relations